Richmond News Now

Microfluidics Market Projected to Grow at a CAGR of 11.8% and is expected to reach USD 522.7 Million by 2028

 Breaking News
  • No posts were found

Microfluidics Market Projected to Grow at a CAGR of 11.8% and is expected to reach USD 522.7 Million by 2028

May 13
14:38 2021
Microfluidics Market Projected to Grow at a CAGR of 11.8% and is expected to reach USD 522.7 Million by 2028

Microfluidics Market
Microfluidics Market Size – USD 15.09 billion in 2020 Market Growth – 11.8% Market Trends – increasing demand for lab-on-a-chip technology

The Global Microfluidics Market size is expected to reach USD 35.23 billion by 2028 at a CAGR of 11.8% according to a new report by Reports and Data.

Microfluidics has been used in the study of antibiotic-resistant bacteria, nanoparticle transport in blood, and chemical reaction kinetics, to name a few. As a result of the increased importance of research, the microfluidics market is expected to rise in revenue. Cancer and pathogen detection are two diagnostic applications of microfluidics that have tremendous economic and technical potential for the microfluidics industry. Microfluidic instruments are used to measure molecular diffusion coefficients, fluid viscosity, pH, and chemical binding coefficients. In the pharmaceutical industry, microfluidic systems are used for a variety of analytical purposes in biopharmaceutical production, including monitoring and optimising protein drug production and assays involving human cells.

The costly R&D process needed to develop microfluidic devices and make them commercially viable may be a stumbling block for the microfluidics industry. However, attempts are being made to make this possible.

Asia Pacific is projected to be the fastest-growing area due to advanced research infrastructure, low labour costs, and the adoption of microfluidic platforms. This underserved market has piqued the attention of foreign investors.

Key Highlights from the Report

  • In February 2021, Fluidigm, a market leader in microfluidics, announced that fourth-quarter revenues rose 38 percent year over year as demand for COVID-19 research drove sales. According to estimates, the company’s microfluidics revenues grew by 98 percent in Q4 to USD 21 million.
  • In order to resolve fluid volume manipulation issues in current microfluidic control systems, Fluigent developed the MFCSTM series of microfluidic systems based on its patented FASTAB technology, which features pressure-controlled flow control that allows a pulseless flow and greater responsiveness.
  • In recent years, microfluidics has become increasingly important in PCR because it allows for the integration of the entire biological process, resulting in multiplexed, high-throughput, and highly parallel assays. As a result, the medical technology segment led the industry in terms of sales.
  • Due to the coronavirus pandemic, demand for microfluidic PCR devices has skyrocketed. Every day, millions of tests were demanded to identify the virus and to distinguish the infected from the healthy. In 2020, the microfluidics industry witnessed unprecedented sales growth as a result of this.
  • In 2020, the lab-on-a-chip segment dominated the microfluidics industry, and this dominance is expected to continue during the forecast period.
  • In 2020, the PDMS-based microfluidic chips segment had the largest revenue share, and it is projected to rise at the fastest rate during the forecast period.
  • Due to the presence of well-established industry leaders, financial support and resource availability for microfluidics research, advanced technologies, and high demand for POC diagnostics, the microfluidics market in North America held the largest revenue share.
  • Some of the key industry contributors are Illumina, Inc.; F. Hoffmann-La Roche Ltd; PerkinElmer, Inc.; Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; Danaher Corporation; Life Technologies Corporation; Abbott Laboratories Thermo Fisher Scientific; Qiagen; Biomérieux; Elveflow; Cellix Ltd.; Micronit Micro Technologies B.V.; and Fluidigm Corporation.


Get a sample of the report @
https://www.reportsanddata.com/sample-enquiry-form/3871

Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2028. For this study, Reports and Data has segmented the global microfluidics market report based on technology, application, material, and region:

Technology Outlook (Revenue, USD Million, 2018 – 2028)

  • Medical/Healthcare
    • PCR & RT-PCR
    • Gel Electrophoresis
    • Microarrays
    • ELISA
    • Others
  • Non-Medical

Application Outlook (Revenue, USD Million, 2018 – 2028)

  • Lab-on-a-chip
    • Medical
    • Non-Medical
  • Organs-on-chips
    • Medical
    • Non-Medical
  • Continuous flow microfluidics
    • Medical
    • Non-Medical
  • Optofluidics and microfluidics
    • Medical
    • Non-Medical
  • Acoustofluidics and microfluidics
    • Medical
    • Non-Medical
  • Electrophoresis and microfluidics
    • Medical
    • Non-Medical

Material Outlook (Revenue, USD Million, 2018 – 2028)

  • Silicon
  • Glass
  • Polymer
  • PDMS
  • Others

Regional Outlook (Revenue, USD Million, 2018 – 2028)

  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
  • Asia Pacific
    • India
    • China
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/3871

Table of Contents

Chapter 1 Executive Summary
                 1.1 Market Snapshot
Chapter 2 Research Methodology
                 2.1 Information Procurement
                 2.2 Information Or Data Analysis
                 2.3 Market Formulation & Validation
Chapter 3 Microfluidics Market Variables, Trends & Scope
                 3.1 Market Segmentation & Scope
                 3.2 Market Lineage Outlook
                     3.2.1. Parent Market Outlook
                     3.2.2. Related/Ancillary Market Outlook
                 3.3 Penetration & Growth Prospect Mapping For Materials, 2019
                 3.4 Microfluidics Market-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
                 3.5 Industry Analysis – Porter’s
                 3.6 Market Driver Analysis
                     3.6.1 Increasing Demand For Low Volume Sample Analysis
                     3.6.2 Growing Penetration Of Microfluidics In Diagnostics Market
                     3.6.3 Introduction Of Advanced Technologies
                 3.7 Market Restraint Analysis
                     3.7.1 High Operational Cost
                     3.7.2 Interfacing And Integration
                     3.7.3 Complex Fabrication Process
                 3.8 Market Opportunity Analysis
                     3.8.1 Investments By Companies In Technological Advancements
                     3.8.2 Growing Adoption Of Point-Of-Care (Poc) Tests
                     3.8.3 Expansion Of Application Scope For Microfluidics Technology
                 3.9 Manufacturing Practices & Trends
                     3.9.1 Photomask Fabrication
                     3.9.2 Photolithography Process
                         3.9.2.1 Methacrylate Coating
                         3.9.2.2 UV Exposure
                         3.9.2.3 Washing
                     3.9.3 Molding Microfluidic Chips
                         3.9.3.1 Soft Lithography
                         3.9.3.2 Soft Embossing
                     3.9.4 Microfabrication
Chapter 4 Microfluidics Market Categorization: Technology Estimates & Trend Analysis
                 4.1 Microfluidics Market: Technology Movement Analysis
                 4.2 Medical/Healthcare
                     4.2.1 Microfluidics Market For Medical/Healthcare, 2018 – 2028 (USD Million)
                     4.2.2 PCR
                         4.2.2.1 Microfluidics Market For PCR, 2018 – 2028 (USD Million)
                     4.2.3 Gel Electrophoresis
                         4.2.3.1 Microfluidics Market For Gel Electrophoresis, 2018 – 2028 (USD Million)
                     4.2.4 Microarrays
                         4.2.4.1 Microfluidics Market For Microarrays, 2018 – 2028 (USD Million)
                     4.2.5 Enzyme-Linked Immunosorbent Assay (Elisa)
                         4.2.5.1 Microfluidics Market For Elisa, 2018 – 2028 (USD Million)
                     4.2.6 Others
                         4.2.6.1 Microfluidics Market For Other Technologies, 2018 – 2028 (USD Million)
                 4.3 Non-Medical
                     4.3.1 Non-Medical Microfluidics Market, 2018 – 2028 (USD Million)
Chapter 5 Microfluidics Market Categorization: Material Estimates & Trend Analysis

Continued…..

Media Contact
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Phone: +1-212-710-1370
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States
Website: https://www.reportsanddata.com/press-release/global-microfluidics-market